Patent File Information
Application Information
Applicants
Person No Name Address
6801224 ELI LILLY AND COMPANY
Inventors
Person No Name Address
7695833 James Benedict CANAVAN C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695834 Stuart William FRIEDRICH C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695837 Jay Lawrence TUTTLE C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695836 Catherine MILCH C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695835 Kathryn Ann KRUEGER C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
Invention Information
Name Of Invention Ülseratif kolit tedavisinde mirikizumab.
Summary Of Invention Mevcut buluş, ülseratif kolit tedavisi usullerinde kullanıma yönelik mirikizumab ile ilgilidir.
Attorney Information
Name SULTAN PINAR ŞEN
STOCK FİKRİ MÜLKİYET HİZMETLERİ ANONİM ŞİRKETİ
Address BÜYÜKDERE CAD. NO:173 LEVENT - ŞİŞLİ- 34394/ İSTANBUL
Priority Information
Date of Priority Priority Number Country of Priority
30-03-2018 US 201862650314P US
Classes of The Invention
IPC
A61K39/395
C07K16/24
A61P1/04
Patent Application Procedures
Date Date of Notification Operation Document
28-02-2025 Yıllık Ücret Ödeme Talebi
22-05-2024 Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
20-05-2024 EPO'dan Gelen Patent Fasikül
Publications
Publication Date Description
21-06-2024 Avrupa Patent Fasiküllerinin İlanı
Payment Dates
Row Year Payment Date Amount Paid (₺)
7 2025 28-02-2025 6280.0